Dr. Philip Sarrel presented a compelling case for expanding hormonal therapy conversations to encompass mental as well as physical health. Citing epidemiological studies and his clinical experience, Sarrel linked untreated menopause—and its often-ignored psychological effects—to a tangible rise in healthcare utilization ranging from ER visits for insomnia and anxiety to increased rates of psychiatric medication use.

Sarrel articulated that HRT, when indicated and chosen in collaboration with patients, not only alleviates vasomotor symptoms but may also reduce instances of mood volatility, sleep disruption, and cognitive difficulties that can profoundly affect both quality of life and long-term health trajectories. He called attention to the cascading socioeconomic effects when women are unable to work or require additional support due to unaddressed symptoms and comorbid anxiety or depression.

Dr. Sarrel called for regulatory and educational reform that promotes holistic, multidisciplinary care for menopausal women. He closed with a call to healthcare systems and policymakers to view menopause management as a matter of overall public health, rather than a niche specialty.